Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Irinotecan, Capecitabine
Sponsor: National Cancer Center, Korea
Collaborators: Asan Medical Center|Chung-Ang University|Inha University Hospital|Korea University Anam Hospital|Samsung Medical Center|Severance Hospital|Seoul National University Hospital|Seoul National University Bundang Hospital